Cargando…
Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant strains of these organisms: is CRRT responsible for this situation?
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718336/ https://www.ncbi.nlm.nih.gov/pubmed/33275170 http://dx.doi.org/10.1186/s13613-020-00781-6 |
| _version_ | 1783619485811343360 |
|---|---|
| author | Kothekar, Amol Divatia, Jigeeshu Vasishtha Myatra, Sheila Nainan Gota, Vikram |
| author_facet | Kothekar, Amol Divatia, Jigeeshu Vasishtha Myatra, Sheila Nainan Gota, Vikram |
| author_sort | Kothekar, Amol |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7718336 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77183362020-12-07 Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant strains of these organisms: is CRRT responsible for this situation? Kothekar, Amol Divatia, Jigeeshu Vasishtha Myatra, Sheila Nainan Gota, Vikram Ann Intensive Care Letter to the Editor Springer International Publishing 2020-12-04 /pmc/articles/PMC7718336/ /pubmed/33275170 http://dx.doi.org/10.1186/s13613-020-00781-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Letter to the Editor Kothekar, Amol Divatia, Jigeeshu Vasishtha Myatra, Sheila Nainan Gota, Vikram Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant strains of these organisms: is CRRT responsible for this situation? |
| title | Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant strains of these organisms: is CRRT responsible for this situation? |
| title_full | Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant strains of these organisms: is CRRT responsible for this situation? |
| title_fullStr | Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant strains of these organisms: is CRRT responsible for this situation? |
| title_full_unstemmed | Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant strains of these organisms: is CRRT responsible for this situation? |
| title_short | Response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against nonresistant strains of these organisms: is CRRT responsible for this situation? |
| title_sort | response to: 500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal pk/pd against nonresistant strains of these organisms: is crrt responsible for this situation? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718336/ https://www.ncbi.nlm.nih.gov/pubmed/33275170 http://dx.doi.org/10.1186/s13613-020-00781-6 |
| work_keys_str_mv | AT kothekaramol responseto500mgasbolusfollowedbyanextendedinfusionof1500mgofmeropenemevery8hfailedtoachieveinonethirdofthepatientsanoptimalpkpdagainstnonresistantstrainsoftheseorganismsiscrrtresponsibleforthissituation AT divatiajigeeshuvasishtha responseto500mgasbolusfollowedbyanextendedinfusionof1500mgofmeropenemevery8hfailedtoachieveinonethirdofthepatientsanoptimalpkpdagainstnonresistantstrainsoftheseorganismsiscrrtresponsibleforthissituation AT myatrasheilanainan responseto500mgasbolusfollowedbyanextendedinfusionof1500mgofmeropenemevery8hfailedtoachieveinonethirdofthepatientsanoptimalpkpdagainstnonresistantstrainsoftheseorganismsiscrrtresponsibleforthissituation AT gotavikram responseto500mgasbolusfollowedbyanextendedinfusionof1500mgofmeropenemevery8hfailedtoachieveinonethirdofthepatientsanoptimalpkpdagainstnonresistantstrainsoftheseorganismsiscrrtresponsibleforthissituation |